Drug
High Dose Inactivated
High Dose Inactivated: highest development phase Phase 3, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| High-Dose Inactivated, Split-Virion Influenza Vaccine NCT00391053 | Phase 3 | Orthomyxoviridae Infection |
Latest
No recent events.
Follow High Dose Inactivated on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.